Home

Joshua Resnick

CIK 1690959 · last filed 2026-06-22

Joshua Resnick is a corporate insider who has filed 22 SEC Form 4 insider transactions across 6 companies since 2016. The most recent filing, for PEPG, was dated Jun 22, 2026.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

6

Total Filings

22

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
ONE BOSTON PLACE
201 WASHINGTON STREET, SUITE 3900
BOSTON, MA 02108
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PEPG Director — $2.72 — $0 5 2026-06-22
SION Director — $5.51 — $0 2 2026-06-18
Cidara Therapeutics, Inc. (CDTX) Delisted Director — $221.38 — $0 3 2026-01-07
VOR Director — $19.37 — $0 5 2025-05-23
Jade Biosciences, Inc. (AVTE) Delisted Director — $93.80 — $0 4 2024-06-07
KalVista Pharmaceuticals, Inc. (KALV) Delisted Director 2,508,279 $27.00 $67.72M $0 3 2017-09-29

Recent Filings

22 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-22 PEPG Grant (A) — $0 EDGAR
2026-06-18 SION Grant (A) — $0 EDGAR
2026-01-07 Cidara Therapeutics, Inc. (CDTX) Delisted Disp (D) — $0 EDGAR
2025-06-18 Cidara Therapeutics, Inc. (CDTX) Delisted Grant (A) — $0 EDGAR
2025-06-16 SION Grant (A) — $0 EDGAR
2025-06-06 PEPG Grant (A) — $0 EDGAR
2025-05-23 VOR Grant (A) — $0 EDGAR
2025-01-07 Cidara Therapeutics, Inc. (CDTX) Delisted Grant (A) — $0 EDGAR
2024-06-21 PEPG Grant (A) — $0 EDGAR
2024-06-07 Jade Biosciences, Inc. (AVTE) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 22
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.